Parallel Advisors, LLC Boston Scientific Corp Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 13,258 shares of BSX stock, worth $1.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,258
Previous 11,790 12.45%
Holding current value
$1.22 Million
Previous $907,000 22.49%
% of portfolio
0.03%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$72.96 - $84.0 $107,105 - $123,312
1,468 Added 12.45%
13,258 $1.11 Million
Q2 2024

Aug 08, 2024
BUY
$67.33 - $77.71 $105,169 - $121,383
1,562 Added 15.27%
11,790 $907,000
Q1 2024

May 06, 2024
BUY
$57.6 - $68.62 $29,894 - $35,613
519 Added 5.35%
10,228 $700,000
Q4 2023

Feb 09, 2024
SELL
$48.64 - $57.81 $16,294 - $19,366
-335 Reduced 3.34%
9,709 $561,000
Q3 2023

May 20, 2024
BUY
$50.19 - $54.68 $22,183 - $24,168
442 Added 4.6%
10,044 $530,000
Q3 2023

Nov 13, 2023
BUY
$50.19 - $54.68 $22,183 - $24,168
442 Added 4.6%
10,044 $530,000
Q2 2023

May 20, 2024
BUY
$49.72 - $54.64 $22,672 - $24,915
456 Added 4.99%
9,602 $519,000
Q2 2023

Aug 04, 2023
BUY
$49.72 - $54.64 $22,672 - $24,915
456 Added 4.99%
9,602 $519,000
Q1 2023

May 20, 2024
SELL
$45.09 - $50.03 $48,787 - $54,132
-1,082 Reduced 10.58%
9,146 $457,000
Q1 2023

Apr 25, 2023
BUY
$45.09 - $50.03 $61,683 - $68,441
1,368 Added 17.59%
9,146 $457,000
Q4 2022

Feb 03, 2023
BUY
$39.56 - $47.22 $5,221 - $6,233
132 Added 1.73%
7,778 $359,000
Q3 2022

Nov 10, 2022
BUY
$36.71 - $109.66 $53,119 - $158,678
1,447 Added 23.34%
7,646 $296,000
Q2 2022

Aug 01, 2022
SELL
$35.24 - $47.1 $53,917 - $72,063
-1,530 Reduced 19.8%
6,199 $231,000
Q1 2022

Apr 28, 2022
BUY
$40.9 - $45.1 $42,045 - $46,362
1,028 Added 15.34%
7,729 $345,000
Q4 2021

Jan 20, 2022
SELL
$38.07 - $44.87 $31,141 - $36,703
-818 Reduced 10.88%
6,701 $285,000
Q3 2021

Nov 02, 2021
BUY
$41.23 - $45.88 $73,100 - $81,345
1,773 Added 30.86%
7,519 $326,000
Q2 2021

Aug 06, 2021
BUY
$38.58 - $44.24 $53,278 - $61,095
1,381 Added 31.64%
5,746 $246,000
Q1 2021

Apr 23, 2021
BUY
$35.27 - $39.67 $25,500 - $28,681
723 Added 19.85%
4,365 $169,000
Q4 2020

Feb 02, 2021
SELL
$33.15 - $41.97 $48,365 - $61,234
-1,459 Reduced 28.6%
3,642 $131,000
Q3 2020

Oct 27, 2020
SELL
$34.44 - $42.23 $3,857 - $4,729
-112 Reduced 2.15%
5,101 $195,000
Q2 2020

Jul 16, 2020
BUY
$30.19 - $39.11 $90 - $117
3 Added 0.06%
5,213 $183,000
Q1 2020

Apr 27, 2020
SELL
$25.83 - $45.71 $5,734 - $10,147
-222 Reduced 4.09%
5,210 $170,000
Q4 2019

Jan 30, 2020
BUY
$37.87 - $45.37 $53,283 - $63,835
1,407 Added 34.96%
5,432 $246,000
Q3 2019

Nov 01, 2019
BUY
$40.31 - $43.45 $29,023 - $31,284
720 Added 21.79%
4,025 $164,000
Q2 2019

Aug 05, 2019
SELL
$34.91 - $42.98 $5,096 - $6,275
-146 Reduced 4.23%
3,305 $142,000
Q1 2019

May 01, 2019
BUY
$32.91 - $40.75 $4,640 - $5,745
141 Added 4.26%
3,451 $132,000
Q4 2018

Feb 05, 2019
BUY
$31.73 - $39.04 $16,753 - $20,613
528 Added 18.98%
3,310 $116,000
Q3 2018

Nov 01, 2018
BUY
$32.83 - $38.63 $9,520 - $11,202
290 Added 11.64%
2,782 $107,000
Q1 2018

May 08, 2018
BUY
$25.2 - $28.54 $151 - $171
6 Added 0.24%
2,492 $68,000
Q4 2017

Feb 13, 2018
SELL
$24.79 - $29.8 $3,123 - $3,754
-126 Reduced 4.82%
2,486 $62,000
Q3 2017

Nov 15, 2017
BUY
$26.26 - $29.17 $68,591 - $76,192
2,612 New
2,612 $74,000
Q3 2017

Nov 14, 2017
SELL
$26.26 - $29.17 $67,514 - $74,996
-2,571 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
2,571
2,571 $68,000

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $132B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email